List of articles with "Chengdu"

Keymed Biosciences 2024 Results

2025-03-26 15:15:52

China Chengdu Keymed Biosciences Stapokibart CM310

Kelun-Biotech 2024 Results

2025-03-26 10:41:50

China Chengdu biotechnology Kelun-Biotech TROP2 ADC

SKB107 NMPA Approval

2025-03-26 08:03:29

China Chengdu Kelun-Biotech SKB107 Bone Metastasis

Chengdu Cultural Conference

2025-03-23 03:53:48

China Chengdu Cultural Industry Creative Events

Chengdu Cultural Conference

2025-03-23 03:53:30

China Chengdu Creative Economy Cultural Industry

Chengdu Cultural Conference

2025-03-23 03:53:16

China Chengdu Global Innovation Cultural Conference

Chengdu Cultural Conference

2025-03-22 01:40:19

China Chengdu Cultural Industry Creative Sector

BGM Acquires YX for AI Growth

2025-03-19 12:42:39

China BGM Group Chengdu AI Strategy YX Management

Sacituzumab Update

2025-03-10 10:50:52

China Chengdu Kelun-Biotech Sacituzumab Lung Cancer

BGM Group Reshuffle

2025-02-28 13:42:35

China BGM Group Chengdu Chen Xin Zhanchang Xin

Starlight Shines Event

2025-02-28 07:15:10

China Chengdu Mini-Drama Starlight Shines

Starlight Shines Event

2025-02-28 07:14:53

China Chengdu Cultural Event Mini-Series

Starlight Shines Event

2025-02-28 07:03:13

China Chengdu FanXing Index Mini-Drama Night Chengdu Event

Mini-Drama Night

2025-02-26 07:47:12

China Chengdu Mini-Drama FanXing Index

BGM Group and AI

2025-02-19 12:41:23

China BGM Group Chengdu AI Strategy Duxiaobao

Stapokibart Approval!

2025-02-10 05:02:36

China Chengdu Keymed Biosciences Stapokibart IL-4Rα

Keymed's Stapokibart Approval

2025-02-10 05:02:17

China Chengdu Keymed Biosciences Stapokibart NMPA

Stapokibart Approval

2025-02-10 05:01:39

China Chengdu Stapokibart Keymed Allergy Treatment

Stapokibart Approved!

2025-02-08 01:53:46

China Chengdu Keymed Biosciences Stapokibart Allergic Rhinitis

Stapokibart Approval

2025-02-08 01:20:22

China Chengdu Keymed Biosciences Stapokibart Kangyueda

Tagitanlimab Approved

2025-01-23 05:36:23

China Chengdu Kelun-Biotech Tagitanlimab Nasopharyngeal-Cancer

Kelun-Biotech's New License Deal

2025-01-11 08:45:19

China Chengdu Kelun-Biotech Windward Bio TSLP Antibody

TDM-180935 Trial Success

2025-01-06 13:26:38

China Chengdu Atopic Dermatitis Technoderma TDM-180935

BGM's Strategic Acquisition

2024-12-27 14:34:25

China BGM Group Chengdu AI Technology AIX Inc

Approval for Stapokibart

2024-12-25 01:35:25

China Chengdu Keymed Biosciences Stapokibart Kangyueda

Stapokibart Approval

2024-12-24 02:07:28

China Chengdu Keymed Biosciences Stapokibart Kangyueda

Stapokibart Approval

2024-12-24 01:57:01

China Chengdu Keymed Biosciences Stapokibart Chronic Rhinosinusitis

Approval for Stapokibart

2024-12-23 14:56:27

China Chengdu Keymed Biosciences Stapokibart Chronic Rhinosinusitis

Keymed's Stapokibart Approval

2024-12-23 14:51:37

China Chengdu Keymed Biosciences Stapokibart Chronic Rhinosinusitis

BGM and Jointown Unite

2024-12-19 14:02:36

China BGM Group Chengdu pharmaceutical Jointown

Fangzhou's AI Agent Solution

2024-12-02 07:26:58

China Chengdu Fangzhou Inc Tencent Baidu

BGM Group Ltd. Innovates

2024-11-29 14:10:57

China Chengdu BGM Group Ltd AIX Inc healthcare integration

Kelun-Biotech’s New TNBC Drug

2024-11-27 06:38:10

China Chengdu Kelun-Biotech Sacituzumab TNBC

BGM and Guilin Pharma Partner

2024-11-22 13:46:17

China BGM Group Guilin Pharma Qilian Pharma Chengdu